Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Acrivon Therapeutics, Inc. | 52,992 | reported | 18 May 2026 | tx 17+336,773−5,622 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 May 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 38,584 | 0.00 USD | |
| 14 May 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 404 | 1.92 USD | |
| 01 Mar 2026 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 94,946 | 0.00 USD | deriv |
| 14 Feb 2026 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 471 | 1.63 USD | |
| 14 Nov 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 403 | 2.24 USD | |
| 14 Aug 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 403 | 1.39 USD | |
| 14 May 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 403 | 1.14 USD | |
| 01 Mar 2025 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 78,078 | 0.00 USD | deriv |
| 14 Feb 2025 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 469 | 5.42 USD | |
| 01 Mar 2024 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 45,045 | 0.00 USD | deriv |
| 14 Nov 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 402 | 7.92 USD | |
| 14 Aug 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 402 | 7.02 USD | |
| 14 May 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 402 | 8.36 USD | |
| 14 Feb 2024 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 468 | 3.40 USD | |
| 14 Nov 2023 | TAX_WITHHOLDING | Acrivon Therapeutics, Inc. | 1,395 | 5.08 USD | |
| 14 Nov 2022 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 20,030 | 0.00 USD | |
| 14 Nov 2022 | GRANT_AWARD | Acrivon Therapeutics, Inc. | 60,090 | 0.00 USD | deriv |